3006.93.10.00/Blinded Placebo Aspirin Tablets for Migraine Trial/China

Blinded Placebo Aspirin Tablets for Migraine Trial from China

These are inert placebo tablets identical in appearance to aspirin, packaged with actual aspirin medicinal preparations in blinded kits for a recognized clinical trial on migraine relief. They fall under HTS 3006.93.10.00 as placebos put up in measured doses, packaged alongside medicinal preparations for double-blinded studies. This ensures neither participants nor researchers know who receives the active drug.

Duty Rate — China → United States

100%

Rate breakdown

9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate

9903.05.860%Universal product exemption (U.S. note 52(b))

9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)

Calculate with your customs value Verify classification with AI

Import Tips

• Obtain FDA Investigational New Drug (IND) approval and provide clinical trial protocol documentation to Customs for clearance

• Label kits clearly as 'Clinical Trial Materials - Not for Resale' to avoid misclassification as commercial medicaments

• Verify sterility certificates and measured dose packaging to prevent reclassification under general pharmaceutical headings